Searched for
TAZOBACTAM
Superbugs on the rise: One lakh lab samples show routine antibiotics no longer effective in IndiaIndia's common infections are becoming untreatable as widely used antibiotics lose efficacy, according to a new ICMR report. Bacteria causi...- Pharma market in good health; lifestyle diseases may be risingThe other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the therapy segment, the...
- Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...
- Sustained rise in antimicrobial resistance in India: ICMR studyA study by ICMR revealed that Klebsiella pneumoniae and Acinetobacter baumannii showed resistance to imipenem among ICU patients with blood...
- Antibiotics becoming ineffective against diseases like typhoid, pneumonia, and urinary infections: ICMR rings alarmA recent ICMR report highlights a troubling rise in antibiotic resistance in India. Diseases like UTIs, blood infections, pneumonia, and ty...
- Stocks in news: JSW Infra, Stanley Lifestyles, SAMHI Hotels, Bank Of Baroda, IREDAIndicating that the company is still interested in the mega Tajpur deep sea port in West Bengal, JSW Infrastructure Ltd said that it remain...
- Orchid Pharma's new antibiotic 'Exblifeb' gets European Medicines Agency approvalThe Chennai-based firm said Exblifeb incorporates Enmetazobactam, "the first completely invented-in-India Beta Lactamase inhibitor" and it ...
- Medley-Cipla deal talks called off over valuation issuesThis is the second pharma merger and acquisition (M&A) transaction that has been called off or postponed recently due to market volatility ...
- Cipla, JB Chemicals, Torrent lead Rs 4,500-crore race for Medley PharmaSet up in 1969 by Sami Khatib as Medley Laboratories, the Mumbai-based privately held company, now called Medley Pharmaceuticals, ranks amo...
- Pfizer Inc recalls 1.8 million vials of antibiotics"Piperacillin and tazobactam have been found to contain elevated levels of impurities that may result in decreased potency," a notification...
- Aurobindo Pharma's arm recalls 2 antibiotic injections from USAccording to a letter issued to the USFDA, the recall of Ampicillin and Sulbactam has been initiated due to customer complaints of the pres...
- Aurobindo Pharma shares fall; company comes under USFDA lens, againShares of Aurobindo Pharma fell 4 per cent in intraday trade on Wednesday as the company again came under the USFDA lens.
- Aurobindo Pharma comes under USFDA lens, againDuring a recent week-long inspection at its Unit 12 manufacturing site, USFDA raised issues related to the quality management.
- Orchid gets USFDA nod for injection, gets 6-mth exclusivityPharma firm Orchid Chemicals & Pharmaceuticals today said it has received the US drug regulator's nod for its Piperacillin and Tazobactam i...
- Orchid Chem recieves EU approval for bacterial injectionOrchid Chemicals and Pharmaceuticals on Monday said it has received European Union regulatory approval for marketing Piperacillin and Tazob...
- Orchid gets MHPRA approval for APIOrchid Chemicals & Pharmaceuticals' has received Medicines and Healthcare products Regulatory Agency (MHRA) approval for its Betalactam Act...
Load More
